Conference News

Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update

Please join us to hear Omar F. Abou-Ezzeddine, M.D.C.M., M.S., at the Lawrence Blacher, M.D., Memorial Lecture, where he will provide a 2026 update on amyloid cardiomyopathy, highlighting current diagnostic strategies, emerging therapies, and practical approaches to patient care.

  • March 20, 2026

  • 1 min

Share

  • 1

    Conference on cardiac amyloidosis on April 16,

  • 2

    Features Dr. Omar F. Abou-Ezzeddine.

  • 3

    Discusses diagnosis and management.

  • 4

    Highlights advances in imaging and biomarkers.

  • 5

    Focus on emerging therapies.

  • 6

    Importance of early recognition emphasized.

  • 7

    Participants will learn supportive management strategies.

Original Source(s)

Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update

  • March 20, 2026

Related Content

ECPR Shows Promise in Cardiac Arrest

Timing, patient selection, and system factors continue to shape its role

Statins and Survival After 80

Cohort analysis associates primary prevention with lower mortality and coronary morbidity

PREVENT Equations Show How Age, Risk Factors Shape CVD Risk

Systematic analysis demonstrates how kidney disease, diabetes, and other factors accelerate 10-year cardiovascular risk, helping guide clinician–patient prevention discussions.